Published on 15 May 2023 on Zacks via Yahoo Finance
Onconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates
Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -3.70%. A quarter ago, it was expected that this company would post a loss of $0.27 per share when it actually produced a loss of $0.26, delivering a surprise of 3.70%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.